673 related articles for article (PubMed ID: 31396308)
21. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis.
Cheng X; Ku CH; Siow RC
Free Radic Biol Med; 2013 Sep; 64():4-11. PubMed ID: 23880293
[TBL] [Abstract][Full Text] [Related]
22. Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein-Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery.
Davies TG; Wixted WE; Coyle JE; Griffiths-Jones C; Hearn K; McMenamin R; Norton D; Rich SJ; Richardson C; Saxty G; Willems HM; Woolford AJ; Cottom JE; Kou JP; Yonchuk JG; Feldser HG; Sanchez Y; Foley JP; Bolognese BJ; Logan G; Podolin PL; Yan H; Callahan JF; Heightman TD; Kerns JK
J Med Chem; 2016 Apr; 59(8):3991-4006. PubMed ID: 27031670
[TBL] [Abstract][Full Text] [Related]
23. The Dual Roles of NRF2 in Cancer.
Menegon S; Columbano A; Giordano S
Trends Mol Med; 2016 Jul; 22(7):578-593. PubMed ID: 27263465
[TBL] [Abstract][Full Text] [Related]
24. The role of Nrf2 signaling in counteracting neurodegenerative diseases.
Dinkova-Kostova AT; Kostov RV; Kazantsev AG
FEBS J; 2018 Oct; 285(19):3576-3590. PubMed ID: 29323772
[TBL] [Abstract][Full Text] [Related]
25. Molecular recognition between potential natural inhibitors of the Keap1-Nrf2 complex.
Bello M; Morales-González JA
Int J Biol Macromol; 2017 Dec; 105(Pt 1):981-992. PubMed ID: 28746889
[TBL] [Abstract][Full Text] [Related]
26. Synergistic Interaction Between Heme Oxygenase (HO) and Nuclear-Factor E2- Related Factor-2 (Nrf2) against Oxidative Stress in Cardiovascular Related Diseases.
Ndisang JF
Curr Pharm Des; 2017; 23(10):1465-1470. PubMed ID: 28088909
[TBL] [Abstract][Full Text] [Related]
27. An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment.
Keleku-Lukwete N; Suzuki M; Yamamoto M
Antioxid Redox Signal; 2018 Dec; 29(17):1746-1755. PubMed ID: 28899203
[TBL] [Abstract][Full Text] [Related]
28. A Naturally-Occurring Dominant-Negative Inhibitor of Keap1 Competitively against Its Negative Regulation of Nrf2.
Qiu L; Wang M; Zhu Y; Xiang Y; Zhang Y
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30042301
[TBL] [Abstract][Full Text] [Related]
29. Absolute Amounts and Status of the Nrf2-Keap1-Cul3 Complex within Cells.
Iso T; Suzuki T; Baird L; Yamamoto M
Mol Cell Biol; 2016 Dec; 36(24):3100-3112. PubMed ID: 27697860
[TBL] [Abstract][Full Text] [Related]
30. The complexity of the Nrf2 pathway: beyond the antioxidant response.
Huang Y; Li W; Su ZY; Kong AN
J Nutr Biochem; 2015 Dec; 26(12):1401-13. PubMed ID: 26419687
[TBL] [Abstract][Full Text] [Related]
31. Drug-Repositioning Screening for Keap1-Nrf2 Binding Inhibitors using Fluorescence Correlation Spectroscopy.
Yoshizaki Y; Mori T; Ishigami-Yuasa M; Kikuchi E; Takahashi D; Zeniya M; Nomura N; Mori Y; Araki Y; Ando F; Mandai S; Kasagi Y; Arai Y; Sasaki E; Yoshida S; Kagechika H; Rai T; Uchida S; Sohara E
Sci Rep; 2017 Jun; 7(1):3945. PubMed ID: 28638054
[TBL] [Abstract][Full Text] [Related]
32. Tetrahydrocurcumin and octahydrocurcumin, the primary and final hydrogenated metabolites of curcumin, possess superior hepatic-protective effect against acetaminophen-induced liver injury: Role of CYP2E1 and Keap1-Nrf2 pathway.
Luo DD; Chen JF; Liu JJ; Xie JH; Zhang ZB; Gu JY; Zhuo JY; Huang S; Su ZR; Sun ZH
Food Chem Toxicol; 2019 Jan; 123():349-362. PubMed ID: 30423402
[TBL] [Abstract][Full Text] [Related]
33. Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators.
Jain AD; Potteti H; Richardson BG; Kingsley L; Luciano JP; Ryuzoji AF; Lee H; Krunic A; Mesecar AD; Reddy SP; Moore TW
Eur J Med Chem; 2015 Oct; 103():252-68. PubMed ID: 26363505
[TBL] [Abstract][Full Text] [Related]
34. Activation of Nrf2 attenuates carbonyl stress induced by methylglyoxal in human neuroblastoma cells: Increase in GSH levels is a critical event for the detoxification mechanism.
Nishimoto S; Koike S; Inoue N; Suzuki T; Ogasawara Y
Biochem Biophys Res Commun; 2017 Feb; 483(2):874-879. PubMed ID: 28073699
[TBL] [Abstract][Full Text] [Related]
35. Modulation of NRF2: Biological Dualism in Cancer, Targets and Possible Therapeutic Applications.
Gallorini M; Carradori S; Panieri E; Sova M; Saso L
Antioxid Redox Signal; 2024 Apr; 40(10-12):636-662. PubMed ID: 37470218
[No Abstract] [Full Text] [Related]
36. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure.
Kim HJ; Vaziri ND
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F662-71. PubMed ID: 20007347
[TBL] [Abstract][Full Text] [Related]
37. The role of modulation of antioxidant enzyme systems in the treatment of neurodegenerative diseases.
Obuobi S; Karatayev S; Chai CL; Ee PL; Mátyus P
J Enzyme Inhib Med Chem; 2016; 31(sup3):194-204. PubMed ID: 27389167
[TBL] [Abstract][Full Text] [Related]
38. Toward clinical application of the Keap1-Nrf2 pathway.
Suzuki T; Motohashi H; Yamamoto M
Trends Pharmacol Sci; 2013 Jun; 34(6):340-6. PubMed ID: 23664668
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of miR-200a protects cardiomyocytes against hypoxia-induced apoptosis by modulating the kelch-like ECH-associated protein 1-nuclear factor erythroid 2-related factor 2 signaling axis.
Sun X; Zuo H; Liu C; Yang Y
Int J Mol Med; 2016 Oct; 38(4):1303-11. PubMed ID: 27573160
[TBL] [Abstract][Full Text] [Related]
40. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway.
Soetikno V; Sari FR; Lakshmanan AP; Arumugam S; Harima M; Suzuki K; Kawachi H; Watanabe K
Mol Nutr Food Res; 2013 Sep; 57(9):1649-59. PubMed ID: 23174956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
